These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8890473)

  • 1. Cervicovaginal anti-HIV antibodies in index women from HIV-discordant, exclusively heterosexual, couples.
    Bélec L; Prazuck T; Payan C; Mohamed AS; Cancre N; Hocini H; Malkin JE; Pillot J
    Viral Immunol; 1996; 9(3):155-8. PubMed ID: 8890473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
    Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
    J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
    Lu XS; Bélec L; Pillot J
    J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women.
    Lü FX
    J Clin Lab Anal; 2000; 14(4):188-92. PubMed ID: 10906772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
    Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
    Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
    J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples.
    Choi RY; Levinson P; Guthrie BL; Lohman-Payne B; Bosire R; Liu AY; Hirbod T; Kiarie J; Overbaugh J; John-Stewart G; Broliden K; Farquhar C
    AIDS; 2012 Nov; 26(17):2155-63. PubMed ID: 22948273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
    Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
    J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand.
    Chuachoowong R; Shaffer N; VanCott TC; Chaisilwattana P; Siriwasin W; Waranawat N; Vanprapar N; Young NL; Mastro TD; Lambert JS; Robb ML
    J Infect Dis; 2000 Jun; 181(6):1957-63. PubMed ID: 10837175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
    Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
    J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
    Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.
    Artenstein AW; VanCott TC; Sitz KV; Robb ML; Wagner KF; Veit SC; Rogers AF; Garner RP; Byron JW; Burnett PR; Birx DL
    J Infect Dis; 1997 Feb; 175(2):265-71. PubMed ID: 9203646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.
    Anderson BL; Ghosh M; Raker C; Fahey J; Song Y; Rouse DJ; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2012 Jul; 207(1):65.e1-10. PubMed ID: 22727351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
    Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
    New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalization of the IgG immune response to HIV-1 in breast milk.
    Becquart P; Hocini H; Garin B; Sépou A; Kazatchkine MD; Bélec L
    AIDS; 1999 Jul; 13(11):1323-31. PubMed ID: 10449284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
    Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
    PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
    Mestecky J; Wright PF; Lopalco L; Staats HF; Kozlowski PA; Moldoveanu Z; Alexander RC; Kulhavy R; Pastori C; Maboko L; Riedner G; Zhu Y; Wrinn T; Hoelscher M
    AIDS Res Hum Retroviruses; 2011 May; 27(5):469-86. PubMed ID: 21091128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.